Macro Finance
Sanofi Weighs Takeover of US Drugmaker Insmed
Bloomberg Markets·November 19, 2026·1 min read
Sanofi SA is weighing an acquisition of US drugmaker Insmed Inc., according to people familiar with the matter, in what would be the largest biopharma deal in years. The potential deal highlights Sanofi's push to expand its portfolio. No financial terms were disclosed, and talks may not result in an agreement.
Read at Bloomberg MarketsDaily crypto arcade
Read the news, then play it.
Chainshorts turns crypto headlines into a daily game. Catch up in 60 words, then jump into daily lucky draws for a shot at the pot.